8 min listen
Leflunomide Pharmacology
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
Leflunomide Pharmacology
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
ratings:
Length:
12 minutes
Released:
Feb 25, 2021
Format:
Podcast episode
Description
On this episode, I discuss leflunomide pharmacology. It is classified as a DMARD and is primarily used in rheumatoid arthritis.
Leflunomide carries a boxed warning for hepatoxicity. LFTs must be monitored with its use.
Leflunomide can inhibit CYP2C8 which plays an important role in pioglitazone metabolism. Concentrations of pioglitazone can go up on account of this interaction.
TB screening should be done prior to beginning the immunosuppressant leflunomide.
Leflunomide carries a boxed warning for hepatoxicity. LFTs must be monitored with its use.
Leflunomide can inhibit CYP2C8 which plays an important role in pioglitazone metabolism. Concentrations of pioglitazone can go up on account of this interaction.
TB screening should be done prior to beginning the immunosuppressant leflunomide.
Released:
Feb 25, 2021
Format:
Podcast episode
Titles in the series (100)
Alpha Blockers Pharmacology RLP Episode 017: On this episode, I discuss the pharmacology and side effects of alpha blockers as well as the differences between a selective alpha blocker versus a non-selective alpha blocker. Enjoy! All subscribers to the website/podcast will get access to a FREE T... by Real Life Pharmacology - Pharmacology Education for Health Care Professionals